2017 Italy Coagulation Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape [Updated: 30032017] Prices from USD $402

03:55 EDT 20 Jun 2017 | BioPortfolio Reports

Complete report $6,100. nbsp;DataPack test volumes, sales forecasts, supplier shares $3,950.

VPGMarketResearchrsquo;s new report designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities and develop effective strategies for the Italian coagulation testing market during the next five years.

The report explores business and technological trends in the Italian coagulation testing market; provides estimates of the test volume, as well as sales and market shares for leading instrument and reagent competitors; compares features of major analyzers; profiles leading market players; analyzes potential applications of emerging technologies; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.


The growing costcontainment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the German coagulation diagnostics practice during the next five years. New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.

Italian Market Overview

Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
Estimated universe of facilities performing coagulation tests.
Fiveyear test volume and sales projections.

Business Opportunities and Strategic Recommendations

Product development and business expansion opportunities with significant market appeal.
ldquo;Idealrdquo; product models with tentative prices and operating characteristics.
Alternative market penetration strategies for instrument and reagent suppliers.
Potential market entry barriers and risks.

Current and Emerging Coagulation Tests

Activated Clotting Time ACT 1, Activated Protein C Resistance, Activated PTT APTT, Alpha 2Antiplasmin, Antithrombin III, Bleeding Time, DDimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,nbsp; Factor IX, Factor Ixa, Factor X Stuart Factor, Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/PreKallikrein Factor Activation, Heparin/AntiFactor Xa, HeparinInduced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time PT, Reptilase Time, Thrombin Time, Von Willebrand039;s Factor Fav/Ag, and others.

Sales and Market Share Analysis of Instrument and Reagent Suppliers

Sales and market shares of major instrument and consumable manufactures.

Market Segmentation Analysis

Comprehensive market segmentation analysis, including:

nbsp;nbsp;nbsp;nbsp; Hospitals
nbsp;nbsp;nbsp;nbsp; Commercial/Private Laboratories

Test volume forecasts for over 40 major procedures, by market segment.

Current and Emerging Products

Review of established and new procedures.

Comparison of automated and semiautomated analyzers marketed by Diagnostica Stago, Helena, IL, Roche, Siemens, Sysmex and other suppliers.

Technology Review

Analysis of current and emerging technologies and their potential market applications.

Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Strategies

Strategic assessments ofnbsp;major suppliers and startup firms developing innovative coagulation testing technologies and products, including their sales, product portfolios,
marketing tactics, collaborative arrangements, and new products in Ramp;D.

The companies analyzed in the report include:

nbsp;nbsp;nbsp;nbsp; Abbott
nbsp;nbsp;nbsp;nbsp; ADI/American Diagnostica
nbsp;nbsp;nbsp;nbsp; Alere/Biosite/Inverness
nbsp;nbsp;nbsp;nbsp; AxisShield
nbsp;nbsp;nbsp;nbsp; Beckman Coulter/Danaher
nbsp;nbsp;nbsp;nbsp; Becton Dickinson
nbsp;nbsp;nbsp;nbsp; Bio/Data
nbsp;nbsp;nbsp;nbsp; ChronoLog
nbsp;nbsp;nbsp;nbsp; Corgenix Medical
nbsp;nbsp;nbsp;nbsp; Diagnostica Stago/Trinity Biotech
nbsp;nbsp;nbsp;nbsp; Grifols
nbsp;nbsp;nbsp;nbsp; Helena Laboratories
nbsp;nbsp;nbsp;nbsp; Hyphen BioMed
nbsp;nbsp;nbsp;nbsp; Instrumentation Laboratory
nbsp;nbsp;nbsp;nbsp; ITC/Nexus Dx
nbsp;nbsp;nbsp;nbsp; Roche
nbsp;nbsp;nbsp;nbsp; Siemens
nbsp;nbsp;nbsp;nbsp; Sienco
nbsp;nbsp;nbsp;nbsp; Sysmex
nbsp;nbsp;nbsp;nbsp; Thermo Fisher
nbsp;nbsp;nbsp;nbsp; ZyCare/Alere

Contains 402 pages and 35 tables

Original Article: 2017 Italy Coagulation Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape [Updated: 30032017] Prices from USD $402


More From BioPortfolio on "2017 Italy Coagulation Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape [Updated: 30032017] Prices from USD $402"

Quick Search


Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...